Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Visualizza

español (ES) (288.28 KB - PDF)

Visualizza

čeština (CS) (322.23 KB - PDF)

Visualizza

dansk (DA) (287.53 KB - PDF)

Visualizza

Deutsch (DE) (289.53 KB - PDF)

Visualizza

eesti (ET) (276.29 KB - PDF)

Visualizza

ελληνικά (EL) (335.21 KB - PDF)

Visualizza

français (FR) (289.25 KB - PDF)

Visualizza

hrvatski (HR) (307.68 KB - PDF)

Visualizza

latviešu (LV) (334.28 KB - PDF)

Visualizza

Malti (MT) (324.47 KB - PDF)

Visualizza

Nederlands (NL) (287.82 KB - PDF)

Visualizza

polski (PL) (380.69 KB - PDF)

Visualizza

português (PT) (288.12 KB - PDF)

Visualizza

română (RO) (482.45 KB - PDF)

Visualizza

slovenčina (SK) (324.97 KB - PDF)

Visualizza

slovenščina (SL) (318.42 KB - PDF)

Visualizza

suomi (FI) (285.73 KB - PDF)

Visualizza

svenska (SV) (287.15 KB - PDF)

Visualizza

Product information

български (BG) (936.84 KB - PDF)

Visualizza

español (ES) (457.64 KB - PDF)

Visualizza

čeština (CS) (695.23 KB - PDF)

Visualizza

dansk (DA) (443.55 KB - PDF)

Visualizza

Deutsch (DE) (456.17 KB - PDF)

Visualizza

eesti (ET) (460.88 KB - PDF)

Visualizza

ελληνικά (EL) (957.24 KB - PDF)

Visualizza

français (FR) (383.63 KB - PDF)

Visualizza

hrvatski (HR) (504.46 KB - PDF)

Visualizza

italiano (IT) (614.01 KB - PDF)

Visualizza

latviešu (LV) (750.12 KB - PDF)

Visualizza

lietuvių (LT) (673.01 KB - PDF)

Visualizza

magyar (HU) (1.07 MB - PDF)

Visualizza

Malti (MT) (774.79 KB - PDF)

Visualizza

Nederlands (NL) (445.92 KB - PDF)

Visualizza

polski (PL) (1.09 MB - PDF)

Visualizza

português (PT) (456.69 KB - PDF)

Visualizza

română (RO) (807.04 KB - PDF)

Visualizza

slovenčina (SK) (711.68 KB - PDF)

Visualizza

slovenščina (SL) (702.28 KB - PDF)

Visualizza

suomi (FI) (456.54 KB - PDF)

Visualizza

svenska (SV) (441.7 KB - PDF)

Visualizza

Íslenska (IS) (622.5 KB - PDF)

Visualizza

norsk (NO) (656.3 KB - PDF)

Visualizza
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Visualizza

español (ES) (219.22 KB - PDF)

Visualizza

čeština (CS) (262.67 KB - PDF)

Visualizza

dansk (DA) (227.42 KB - PDF)

Visualizza

Deutsch (DE) (218.75 KB - PDF)

Visualizza

eesti (ET) (221.16 KB - PDF)

Visualizza

ελληνικά (EL) (268.37 KB - PDF)

Visualizza

français (FR) (221.14 KB - PDF)

Visualizza

hrvatski (HR) (227.55 KB - PDF)

Visualizza

italiano (IT) (191.92 KB - PDF)

Visualizza

latviešu (LV) (256.74 KB - PDF)

Visualizza

lietuvių (LT) (210.34 KB - PDF)

Visualizza

magyar (HU) (210.45 KB - PDF)

Visualizza

Malti (MT) (250.85 KB - PDF)

Visualizza

Nederlands (NL) (228.06 KB - PDF)

Visualizza

polski (PL) (245.92 KB - PDF)

Visualizza

português (PT) (231.37 KB - PDF)

Visualizza

română (RO) (434.62 KB - PDF)

Visualizza

slovenčina (SK) (253.67 KB - PDF)

Visualizza

slovenščina (SL) (237.31 KB - PDF)

Visualizza

suomi (FI) (204.11 KB - PDF)

Visualizza

svenska (SV) (218.51 KB - PDF)

Visualizza

Íslenska (IS) (185.95 KB - PDF)

Visualizza

norsk (NO) (222.67 KB - PDF)

Visualizza

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page